The therapeutic potential of oxytocin in the treatment of COVID-19 and/or in reducing the hospitalization period is also supported by Buemann et al., who reported the capability of oxytocin in dampening the inflammatory response driven by neutrophils in different animal models and its potential in decreasing the infiltration of inflammatory tissue cells [41]. The gene discussed is OXT; the disease is COVID-19.